Company Name : Bharavi Pharmaceutical Ltd
Address : 76/E, Sardar Estate, Ajwa Road, Vadodara – 390 019 Gujarat, India
Tel No: 91 265 2560394
Email: nilesh@bharavipharmaceuticals.com, inquiry@bharavipharmaceuticals.com
Website : http://www.bharavipharmaceuticals.com/
Company Profile
A young technocrat educated in Europe, having worked as Chemical Engineer in the bulk drug plant of a giant pharmaceutical company and also worked as a works managerin foundation plant, cherished the desire to start a pharmaceutical company to explore the vastly unexplored drugs and medicines of indigenous origin. That is how BHARAVI was born in 1979.A team was formed by addition of a doctor of Ayurveda and a fellow from the Institute of Chartered accountants of India, with a record of successful launching of a bulk drug plant. These three entrepreneurs having expertise &experience in their respective fields contributed very vitally in the growth of BHARAVI in excellent formulation of Ayuervedic & Allopathic drugs.
Bharavi Pharmaceuticals Ltd. is one of the oldest manufacturing unit of the Vadodara ( 30 Yrs.) Engaged in production of Allopathic as well as Herbo-mineral medicine having a strong base of PCD market throughout the country with multi crore turnovers, now company is going to usher OTC market with a multidimensional innovative concept.
Like you, we also believe that competition within OTC market is at its own peak. The main concept OTC market that chemist will push the product to the customers which hardly works. Again, advertisement is a very unpredictable field. After spending lakhs of rupees – no one can be certain that customer will pick the product. Under such circumstances when any middle range company dares to claim that it will prove its presence nationally within mere span of 12 months – it may means something.
People who smoke are also at much higher risk of developing diabetes compared to non-smokers…
17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…
Lonavala, November 12, 2024: As the global cancer burden rises to 30 million cases by…
The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…
By DR UMESH SRIKANTHA, Senior Consultant - Neurosurgery, Head of Spine Services, Aster RV Hospital …
Pune, November 11, 2024: Henkel Adhesives Technologies India Private Limited (Henkel India) announces the opening…